Phase 3 trials are underway, and a realistic approval window is late 2026 at the earliest, more likely 2027
Behavioral recovery in 6-hydroxydopamine-lesioned rats by cotransduction of striatum with tyrosine hydroxylase and aromatic-amino acid decarboxylase genes using two separate adeno-associated virus vectors
So lots of more and more studies are looking at and coming out with, um, you know, It's correlation with improved cognitive function as we age in the realm of Alzheimer's, dementia, it's neuroprotective [00:38:00] benefits from an inflammatory perspective, from a blood sugar, insulin perspective and again, You know, Alzheimer's dementia is a big, big medical burden in our country and is heavily tied in to blood sugar
At Viva Skin Lounge, I strongly believe in a multi-modality approach for the best results